Clinical Trial Update: A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients [NA]

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating whether correcting anemia with recombinant human erythropoietin reduces the progression …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiac Hypertrophy
• Cardiovascular Diseases
• Chronic Kidney Disease

Drugs mentioned

• epoetin alfa (recombinant human erythropoietin) (epoetin alfa)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Chronic Disease, Kidney Diseases | NA | Status: COMPLETED